These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 3867160)

  • 1. [Evaluation of the sensitivity to cytostatics of leukemia cells by labeling with tritiated thymidine and uridine: comparison with clinical response].
    Burgaleta C; Serrano LG; Moreno MT; Dancausa JP
    Sangre (Barc); 1985; 30(5):831-8. PubMed ID: 3867160
    [No Abstract]   [Full Text] [Related]  

  • 2. Nucleus labeling or membrane labeling for studying the proliferation of drug treated cells?
    Boutonnat J; Barbier M; Ronot X; Seigneurin D
    Morphologie; 2000 Jun; 84(265):11-5. PubMed ID: 11048293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling of in vitro drug activity and prediction of clinical outcome in acute myeloid leukemia.
    Quartino A; Karlsson MO; Freijs A; Jonsson N; Nygren P; Kristensen J; Lindhagen E; Larsson R
    J Clin Pharmacol; 2007 Aug; 47(8):1014-21. PubMed ID: 17660484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell proliferation in acute promyelocytic leukemia. Studies with thymidine labeling and in vitro colony assay.
    Tura S; Baccarani M; Santucci MA; Ricci P
    Haematologica; 1982 Jun; 67(3):349-55. PubMed ID: 6814992
    [No Abstract]   [Full Text] [Related]  

  • 6. [The trials of determination of acute leukemia blasts sensitivity against cytostatics (author's transl)].
    Grazybek-Hryncewicz K; Biernacka I; Brzuchowska W; Kuliczkowski K; Luczkiewicz-Mulczykowa A; Kotlarek-Haus S
    Przegl Lek; 1981; 38(2):289-94. PubMed ID: 6941335
    [No Abstract]   [Full Text] [Related]  

  • 7. Combinations of stem cell factor with other hematopoietic growth factors enhance growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia.
    Inatomi Y; Toyama K; Clark SC; Shimizu K; Miyauchi J
    Cancer Res; 1994 Jan; 54(2):455-62. PubMed ID: 7506123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
    Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
    Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobilization of hematopoietic progenitors in patients with chronic myeloid leukemia.
    Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; Niewint AW; Ossenkoppele GJ
    Bone Marrow Transplant; 1997 Nov; 20(10):835-42. PubMed ID: 9404923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pretherapeutic sensitivity tests of human leukemia cells against cytostatic drugs in vitro in relation to the in vivo effects].
    Hirschmann WD; Gross R
    Med Welt; 1976 Nov; 27(47):2298-9. PubMed ID: 1004180
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin.
    Morris KL; Adams JA; Liu Yin JA
    Leuk Res; 2009 Aug; 33(8):1096-9. PubMed ID: 19268363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of daunorubicin and cytarabine on cell line NB4].
    Luo ZG; Zhong L; Chen FY; Wang HR; Ouyang RR
    Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):247-9. PubMed ID: 17877202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
    Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
    Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
    Farag SS; Ruppert AS; Mrózek K; Mayer RJ; Stone RM; Carroll AJ; Powell BL; Moore JO; Pettenati MJ; Koduru PR; Stamberg J; Baer MR; Block AW; Vardiman JW; Kolitz JE; Schiffer CA; Larson RA; Bloomfield CD
    J Clin Oncol; 2005 Jan; 23(3):482-93. PubMed ID: 15534356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive chemotherapy with daunorubicin, 5-azacytidine, 6-thioguanine, and cytarabine (DATA) for the blastic transformation of chronic granulocytic leukemia.
    Winton EF; Miller D; Vogler WR
    Cancer Treat Rep; 1981; 65(5-6):389-92. PubMed ID: 6165470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein expression and prognostic value in acute myeloid leukemia.
    Senent L; Jarque I; Martín G; Sempere A; González-García Y; Gomis F; Pérez-Sirvent M; De La Rubia J; Sanz MA
    Haematologica; 1998 Sep; 83(9):783-7. PubMed ID: 9825574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic and cytotoxic effects of cytarabine and daunorubicin on cells in culture.
    Fried J; Perez AG; Doblin J; Clarkson BD
    Cancer Treat Rep; 1981; 65(1-2):153-6. PubMed ID: 7194735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daunorubicin and adriamycin in the treatment of leukemia.
    Klener P; Donner L; Kozená J
    Neoplasma; 1973; 20(1):87-96. PubMed ID: 4573873
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effects of cytosine arabinoside and daunomycin on cell kinetics in childhood acute myeloblastic leukemia].
    Tsukimoto I; Toyosaka H; Tashiro Y; Nagao T
    Rinsho Ketsueki; 1973 Jul; 14(7):762-8. PubMed ID: 4517365
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical usefulness of determination of the sensitivity of myeloblastic leukemia cells to antiproliferative drugs in cell culture in vivo].
    Hansz J; Pytlak B; Drozdowska D
    Acta Haematol Pol; 1981; 12(1):1-6. PubMed ID: 6947679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.